Amber thought her ‘life was over’ when diagnosed with multiple sclerosis (MS) aged just 20. But a drug trial gave her the chance to finish university and manage her condition more effectively. 🎓 📚 She was away from home at the University of Plymouth studying business when she got the news she had relapsing remitting MS. 🧠 MS is a condition that affects the brain and spinal cord for which there is currently no cure, although treatment can often help manage the symptoms, which include fatigue,

📢Up to 60,000 people with relapsing-remitting multiple sclerosis (MS) could benefit from ublituximab - a new treatment option we've recommended for adults with the condition. Learn more: https://www.nice.org.uk/guidance/ta1025?utm_medium=organic&utm_source=facebook&utm_campaign=ublituximab&utm_content=finalvideo | National Institute for Health and Care Excellence